Preclinical Therapy of Cannabinoids

A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma Sofía Torres, Mar Lorente, Fátima Rodríguez-Fornés, Sonia Hernández-Tiedra, María Salazar, Elena García-Taboada, Juan Barcia, Manuel Guzmán and Guillermo Velasco, Authors’ Affiliations: 1Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, 2Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), and 3Department of Neurosurgery, Hospital Clínico San […]

Read more

Antitumor Effects of Cannabidiol

Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines Daniela ParolaroMaria P. Abbracchio andPaola Massi, Angelo Vaccani, Stefania Ceruti, Arianna Colombo, Abstract Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoactivity of cannabinoid compounds limits their medicinal usage, we undertook the present study to evaluate the in vitro antiproliferative ability of cannabidiol (CBD), […]

Read more